Ashwin Kishtagari

2.0k total citations · 1 hit paper
56 papers, 857 citations indexed

About

Ashwin Kishtagari is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Ashwin Kishtagari has authored 56 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Hematology, 26 papers in Genetics and 20 papers in Molecular Biology. Recurrent topics in Ashwin Kishtagari's work include Acute Myeloid Leukemia Research (36 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (20 papers) and Chronic Myeloid Leukemia Treatments (15 papers). Ashwin Kishtagari is often cited by papers focused on Acute Myeloid Leukemia Research (36 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (20 papers) and Chronic Myeloid Leukemia Treatments (15 papers). Ashwin Kishtagari collaborates with scholars based in United States, Italy and Canada. Ashwin Kishtagari's co-authors include Ross L. Levine, Martin S. Tallman, Sean M. Devlin, David B. Solit, David M. Hyman, Ahmet Zehir, Marc Ladanyi, Michael F. Berger, Catherine C. Coombs and Philip Jonsson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Ashwin Kishtagari

52 papers receiving 851 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes

2017 521 citations Catherine C. Coombs, Ahmet Zehir et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashwin Kishtagari United States	11	564	323	305	221	121	56	857
Zineb Hamilou Canada	6	408 0.7×	238 0.7×	265 0.9×	134 0.6×	72 0.6×	18	652
Nicolas Duployez France	17	621 1.1×	303 0.9×	375 1.2×	135 0.6×	79 0.7×	67	950
Leonie Saft Sweden	16	875 1.6×	405 1.3×	298 1.0×	106 0.5×	118 1.0×	37	1.1k
Jane E. Churpek United States	18	621 1.1×	282 0.9×	360 1.2×	241 1.1×	161 1.3×	45	1.1k
Haiyang Yun Germany	14	767 1.4×	277 0.9×	652 2.1×	198 0.9×	63 0.5×	25	1.1k
Maitrayee Goswami United States	16	506 0.9×	304 0.9×	191 0.6×	57 0.3×	165 1.4×	31	735
Nathalie Grardel France	15	848 1.5×	591 1.8×	322 1.1×	117 0.5×	160 1.3×	40	1.3k
Jean Michel Cayuela France	10	481 0.9×	411 1.3×	132 0.4×	66 0.3×	149 1.2×	12	727
Frank J. Godinho United States	7	296 0.5×	102 0.3×	431 1.4×	250 1.1×	193 1.6×	12	849
Anna Aventı́n Spain	20	495 0.9×	317 1.0×	372 1.2×	61 0.3×	152 1.3×	58	938

Countries citing papers authored by Ashwin Kishtagari

Since Specialization

Citations

This map shows the geographic impact of Ashwin Kishtagari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwin Kishtagari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwin Kishtagari more than expected).

Fields of papers citing papers by Ashwin Kishtagari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwin Kishtagari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwin Kishtagari. The network helps show where Ashwin Kishtagari may publish in the future.

Co-authorship network of co-authors of Ashwin Kishtagari

This figure shows the co-authorship network connecting the top 25 collaborators of Ashwin Kishtagari. A scholar is included among the top collaborators of Ashwin Kishtagari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwin Kishtagari. Ashwin Kishtagari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yajing, Cosmin A. Bejan, Caitlyn Vlasschaert, et al.. (2025). Clonal Hematopoiesis of Indeterminate Potential After Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 124(4). 1042–1050.

Brogan, James, Ashwin Kishtagari, Robert W. Corty, et al.. (2025). Incident cytopenia and risk of subsequent myeloid neoplasm in age-related clonal hematopoiesis: a multi-biobank case-control study. EClinicalMedicine. 84. 103283–103283. 1 indexed citations

Ali, Haris, Ashwin Kishtagari, Sanjay Mohan, et al.. (2024). Selinexor-Driven Regulation of Proinflammatory Cytokines May Lead to Stabilization of Hematologic Parameters and Bone Marrow Function in Patients with Myelofibrosis: Case Study from the Phase 1 Sentry Trial. Blood. 144(Supplement 1). 6676–6676. 1 indexed citations

Mack, Taralynn, Caitlyn Vlasschaert, Alexander J. Silver, et al.. (2024). Cost-Effective and Scalable Clonal Hematopoiesis Assay Provides Insight into Clonal Dynamics. Journal of Molecular Diagnostics. 26(7). 563–573. 16 indexed citations

Tantravahi, Srinivas K., Ashwin Kishtagari, Sanjay Mohan, et al.. (2024). MPN-527 Selinexor and Ruxolitinib Impact on Symptom Burden in Patients With Myelofibrosis Is Potentially Driven by Inhibition of NF-κB and Activation of P53 Pathways. Clinical Lymphoma Myeloma & Leukemia. 24. S437–S438. 1 indexed citations

Gurnari, Carmelo, Hussein Awada, Simona Pagliuca, et al.. (2024). Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis. Blood. 144(2). 145–155. 6 indexed citations

Kishtagari, Ashwin, Yajing Li, Caitlyn Vlasschaert, et al.. (2024). Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk. Blood Cancer Journal. 14(1). 6–6. 4 indexed citations

Vachhani, Pankit, Abdulraheem Yacoub, Elie Traer, et al.. (2023). Platelet Response in Pacritinib-Treated Patients with Cytopenic Myelofibrosis: A Retrospective Analysis of PERSIST-2 and PAC203 Studies. Blood. 142(Supplement 1). 4554–4554. 1 indexed citations

Ferrell, P. Brent, et al.. (2023). Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment. Blood Cancer Journal. 13(1). 5–5. 20 indexed citations

10.

Derkach, Andriy, et al.. (2022). Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer. Haematologica. 108(1). 161–170. 2 indexed citations

11.

Sochacki, Andrew, Cosmin A. Bejan, Shilin Zhao, et al.. (2022). Patient-specific comorbidities as prognostic variables for survival in myelofibrosis. Blood Advances. 7(5). 756–767. 8 indexed citations

12.

Pagliuca, Simona, Carmelo Gurnari, Sanghee Hong, et al.. (2021). Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation. JCI Insight. 6(13). 13 indexed citations

13.

Kishtagari, Ashwin & Aaron T. Gerds. (2021). Unmet Need in Essential Thrombocythemia and Polycythemia Vera. Hematology/Oncology Clinics of North America. 35(2). 295–303. 1 indexed citations

14.

Awada, Hassan, Arda Durmaz, Carmelo Gurnari, et al.. (2021). Friend or foe? The case of Wilms' Tumor 1 (WT1) mutations in acute myeloid leukemia. Blood Cells Molecules and Diseases. 88. 102549–102549. 3 indexed citations

15.

Kishtagari, Ashwin & Ross L. Levine. (2020). The Role of Somatic Mutations in Acute Myeloid Leukemia Pathogenesis. Cold Spring Harbor Perspectives in Medicine. 11(4). a034975–a034975. 14 indexed citations

16.

Coombs, Catherine C., Ahmet Zehir, Sean M. Devlin, et al.. (2017). Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. Cell stem cell. 21(3). 374–382.e4. 521 indexed citations breakdown →

17.

Getta, Bartlomiej, Ashwin Kishtagari, Patrick Hilden, et al.. (2017). Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Older Patients with Myelodysplastic Syndromes. Biology of Blood and Marrow Transplantation. 23(7). 1078–1086. 22 indexed citations

18.

Watts, Justin M., Bogdan Dumitriu, Patrick Hilden, et al.. (2016). Telomere length and associations with somatic mutations and clinical outcomes in acute myeloid leukemia. Leukemia Research. 49. 62–65. 15 indexed citations

19.

Glass, Jacob L., Ashwin Kishtagari, Dan Douer, & Martin S. Tallman. (2015). Herpes Zoster Is More Frequent in Patients Receiving Higher Cumulative Doses of Arsenic Trioxide and Is Mitigated By Prophylactic Acyclovir. Blood. 126(23). 3752–3752. 1 indexed citations

20.

Kishtagari, Ashwin, Montreh Tavakkoli, & Jae H. Park. (2014). Survivorship in Adolescents and Young Adults. Acta Haematologica. 132(3-4). 383–390. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact